Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
about
How do we approach thrombocytopenia in critically ill patients?Contemporary treatment of immune thrombocytopenia.DiagnoSTic assays for heparin-induced thrombocytopenia.Management of thrombocytopenia.Proton pump induced thrombocytopenia: A case report and review of literature.Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device.Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH.Drug-induced haemolysis, renal failure, thrombocytopenia and lactic acidosis in patients with HIV and cryptococcal meningitis: a diagnostic challenge.Drug-Induced Thrombocytopenia following a Transvaginal Oocyte Retrieval for In Vitro Fertilization.Immune thrombocytopenia associated with consumption of tonic water.Flucloxacillin-induced immune thrombocytopenia.Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopenia.Vancomycin-induced thrombocytopenia: a rare adverse effect in a patient -submitted to bone graft in the jaw.How we manage immune thrombocytopenia in the elderly.Vancomycin-Induced Thrombocytopenia: A Narrative Review.Itraconazole-induced thrombocytopenia.A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review.Levofloxacin-Induced Acute Immune-Mediated Thrombocytopenia of Rapid-Onset.Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India.Severe Thrombocytopenia During Dolutegravir-containing Antiretroviral Therapy.Meropenem-induced immune thrombocytopenia and the diagnostic process of laboratory testing.A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.Bisoprolol-induced thrombocytopenia: A case report.Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations.Delayed, severe thrombocytemia after abciximab infusion for primary angioplasty in acute coronary syndromes: Moving between systemic bleeding and stent thrombosis.A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion.Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - A prospective cohort study.
P2860
Q30240053-7080DB7F-9010-493B-A228-FF667B1DC669Q33410653-6ECD68C4-C0D2-4F23-9495-F34BEC663C0AQ33415273-598EEF4C-691B-43D5-A1CB-089DB704E1B3Q33416258-EED02EF6-04C9-4932-B42C-38F95C8FD5ACQ33417594-1765FBE2-5B85-41B9-B57B-134E5AF4CBA4Q33417604-BFE9BFDC-8ED1-4AA5-BE7D-53DD051FBD11Q33419883-7821B225-7977-4EBD-900B-592225607633Q33419948-67BB7571-B5F8-4594-B628-7CABBD372A53Q33421470-2FF4D609-DB91-440A-ADED-15D2CB9ED286Q33421628-61AB0A61-F9F5-467E-96DC-D4FEA693D99EQ33425578-9875D3B7-D19E-448B-9FEE-4C7A8E84D93EQ33425721-6935003E-7137-4A06-98AC-B2DB309A6C73Q33427874-5BB14B39-3D23-4B5B-A990-9195F8F16CA7Q33431348-CABD5A95-FBEE-4525-949D-F483DC3C74C2Q33431371-BF6A45A9-D576-4008-BF6C-AE3A9AB89BF6Q33436796-1DF0044B-2A2F-4B20-928F-F8EDF5D39392Q33437238-2BE74490-9002-47CE-8A04-2196EEEC34ADQ33439887-47B883FA-0542-4D09-B64D-199021CB8DDEQ33440946-8A63EB10-6E1E-454E-AC0A-4187F0E5ACC7Q36018463-6E481FAB-0EB2-40D3-AF76-43975523DE5EQ40092935-32A7AD21-408C-4215-A64C-E4A1A2CE8426Q47985251-421374AA-F875-48D0-813B-313A65FD9185Q49549984-231F15D7-35BF-4EC1-91DF-9783A529177CQ50028367-0B329924-E414-4519-9A59-A508DCBE0121Q50227197-C6D10EE7-5D6F-4F6B-BF0E-678BCC88B921Q53120483-5CB299B8-A863-48CF-B4AE-C9015E84D6F4Q53587801-59BB422B-0155-4340-8EBD-F69081CFE200Q55442994-AB3CFB61-5CD6-4B60-8D0D-8A6D7261E6CFQ55453456-10639BFC-E022-413A-A43B-AD78332FD3DD
P2860
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@ast
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@en
type
label
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@ast
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@en
prefLabel
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@ast
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@en
P2093
P2860
P1476
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
@en
P2093
Donald M Arnold
Ishac Nazi
James N George
James W Smith
John G Kelton
Lisa J Toltl
P2860
P304
P356
10.1016/J.TMRV.2013.05.005
P577
2013-07-08T00:00:00Z